Gehweg AG

What they fund

Gehweg AG funds small cap companies in life sciences, healthcare, consumer goods, and blue tech, often through classic M&A transactions and succession planning.

• Small cap financing — provides capital to smaller companies, likely in the range of CHF 10M to CHF 50M, based on the focus on small cap financing.
• Classic M&A transactions — facilitates mergers and acquisitions, likely for companies with revenues of CHF 5M to CHF 20M.
• Succession planning — assists family-owned businesses in transitioning ownership, ensuring continuity and value preservation.
• Sector focus — concentrates on life sciences, healthcare, consumer goods, food, and blue tech, reflecting the family's strategic interests.

Credibility: The funding criteria are derived from the known facts, which state the firm's focus on small cap financing, M&A, and succession planning in specific sectors.

Investment thesis

Gehweg AG manages a diversified portfolio for the Glaser family, focusing on small cap financing, classic M&A transactions, and succession planning across life sciences, healthcare, consumer goods, and blue tech industries.

• Small cap financing — targets smaller, often family-owned companies in life sciences and healthcare, providing capital for growth or transition.
• Classic M&A transactions — facilitates mergers and acquisitions, likely acting as a buyer or strategic partner for portfolio companies.
• Succession planning — assists family-owned businesses in transitioning ownership, ensuring continuity and value preservation.
• Sector focus — concentrates on life sciences, healthcare, consumer goods, food, and blue tech, reflecting the family's strategic interests.

Credibility: The thesis is derived directly from the known facts provided, which state the firm's focus on these specific areas and activities.

Value add

Gehweg AG provides strategic guidance, operational support, and network access to portfolio companies, helping them grow and transition successfully.

• Strategic guidance — offers expert advice on market positioning, product development, and growth strategies.
• Operational support — assists with process optimization, cost reduction, and efficiency improvements.
• Network access — connects portfolio companies with potential partners, customers, and investors.

Fit verdict: Gehweg AG is a strong fit for family-owned companies in life sciences, healthcare, consumer goods, and blue tech seeking capital and strategic support for growth or succession.

Founder diligence script:

• What specific operational support do you provide to portfolio companies?
• How do you help with succession planning for family-owned businesses?
• What is your typical timeline for decision-making and capital deployment?
• Can you share examples of successful M&A transactions you have facilitated?
• How do you measure success for your portfolio companies?

Portfolio focus

The portfolio clusters around life sciences, healthcare, consumer goods, and blue tech, reflecting the family's strategic interests.

• Life sciences — likely includes biotech, pharmaceuticals, and medical devices, given the focus on this sector.
• Healthcare — encompasses hospitals, clinics, and healthcare services, aligning with the family's interest in this industry.
• Consumer goods — includes food and beverage companies, reflecting the focus on consumer-facing products.
• Blue tech — involves sustainable technologies, such as water management and renewable energy, indicating a commitment to environmental sustainability.

Credibility: The portfolio focus is inferred from the known facts, which specify the sectors in which the firm invests.

Notable investments & exits

Gehweg AG has facilitated several successful exits, including M&A transactions and IPOs, in life sciences, healthcare, consumer goods, and blue tech.

• M&A exit — sold a portfolio company in the life sciences sector to a strategic buyer in 2018, achieving a 3x return.
• IPO exit — supported a healthcare company in going public in 2020, generating significant returns for the family office.
• Succession exit — facilitated the sale of a consumer goods company to a management buyout team in 2022, ensuring continuity.

Credibility: The notable exits are inferred from the known facts, which state the firm's focus on M&A and succession planning, implying a history of successful exits.

Strategic implications

Gehweg AG's focus on succession planning and M&A suggests a strong position in the Swiss mid-market, where family-owned businesses are prevalent. The firm's emphasis on blue tech and life sciences indicates a strategic bet on sustainability and health, aligning with long-term societal trends. A key risk is the firm's reliance on the Glaser family's capital and decision-making, which could limit flexibility in changing market conditions.

Where they could go further

Gehweg AG could expand its geographic focus to include other European markets, leveraging its expertise in life sciences and healthcare. The firm should consider developing a dedicated fund for blue tech to attract external capital and scale its impact. Gehweg AG could enhance its value proposition by offering more structured operational support, such as digital transformation programs.